FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

8 results

fluoxetine
(Fluoxetine)
Cadila Pharmaceuticals Limited
Usage: Fluoxetine capsules are indicated for treating Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia Nervosa, and Panic Disorder. They can be combined with Olanzapine for Bipolar I Disorder and Treatment Resistant Depression. Monotherapy is not approved for Bipolar I or treatment-resistant cases.
olanzapine
(Olanzapine)
Ascend Laboratories, LLC
Usage: Oral olanzapine is indicated for treating schizophrenia, bipolar I disorder (manic or mixed episodes), and as an adjunct to lithium or valproate for bipolar I disorder. It is also used in combination with fluoxetine for depressive episodes associated with bipolar I disorder and treatment-resistant depression.
olanzapine
(Olanzapine)
Teva Pharmaceuticals USA, Inc.
Usage: Olanzapine orally disintegrating tablets are indicated for treating schizophrenia, bipolar I disorder (including manic or mixed episodes), and depressive episodes associated with bipolar I when combined with fluoxetine. Pediatric use requires careful consideration of risks. Monotherapy for depressive episodes and treatment-resistant depression is not indicated.
olanzapine
(Olanzapine)
Upsher-Smith Laboratories, LLC
Usage: Olanzapine is indicated for treating schizophrenia, bipolar I disorder (both manic/mixed episodes and maintenance), depressive episodes associated with bipolar I disorder (in combination with fluoxetine), and treatment-resistant depression (also in combination). Cautions exist for pediatric use due to risks like weight gain and dyslipidemia.
olanzapine
(Olanzapine)
Macleods Pharmaceuticals Limited
Usage: Olanzapine orally disintegrating tablets are indicated for the treatment of schizophrenia, bipolar I disorder (both manic/mixed episodes and as adjunctive therapy), depressive episodes associated with bipolar I disorder (in combination with fluoxetine), and treatment-resistant depression (also with fluoxetine). Caution is advised in pediatric patients due to potential risks.
olanzapine
(Olanzapine)
Cadila Pharmaceuticals Limited
Usage: Olanzapine is indicated for treating schizophrenia, bipolar I disorder (manic or mixed episodes), acute agitation in schizophrenia and bipolar I mania, and in combination with fluoxetine for depressive episodes in bipolar I disorder and treatment-resistant depression. Use in adolescents requires careful risk assessment due to potential side effects.
spravato
(Esketamine Hydrochloride)
Janssen Pharmaceuticals Inc.
Usage: SPRAVATO is indicated for treatment-resistant depression in adults (either alone or with an oral antidepressant) and for depressive symptoms in adults with major depressive disorder who have acute suicidal ideation or behavior, also in combination with an oral antidepressant.
zyprexa
(Olanzapine)
Eli Lilly and Company
Usage: ZYPREXA is indicated for treating schizophrenia and bipolar I disorder (manic or mixed episodes), including pediatric patients. It is also used as an adjunct therapy with lithium or valproate. Additionally, ZYPREXA is indicated for acute agitation in schizophrenia and bipolar I mania, and in combination with fluoxetine for bipolar depression and treatment-resistant depression.

Medications for Depressive Disorder Treatmentresistant

fluoxetine

olanzapine

olanzapine

olanzapine

olanzapine

olanzapine

spravato

zyprexa